The clinical symptoms of Parkinson's disease.

Sveinbjornsdottir, Sigurlaug·2016·Journal of Neurochemistry

Cited by (1,402)

Items 601–700 of 1,402

  1. Physical Therapy Effectiveness
    Mário Bernardo-Filho, Danúbia da Cunha de Sá-Caputo, Rédha Taïar · 2019 · IntechOpen eBooks
  2. Stress Response Is the Main Trigger of Sporadic Amyloidoses
    Alexey P. Galkin, Evgeniy I. Sysoev · 2021 · International Journal of Molecular Sciences
  3. REM Sleep Behavior Disorder in Parkinson’s Disease: Change in Cognitive, Psychiatric, and Functional Outcomes from Baseline to 16–47-Month Follow-Up
    Ryan Van Patten, Zanjbeel Mahmood, Delaney Pickell, Jacqueline E. Maye, Scott C. Roesch, Elizabeth W. Twamley, J. Vincent Filoteo, Dawn M. Schiehser · 2021 · Archives of Clinical Neuropsychology
  4. Donepezil for Constipation in Lewy Body Diseases: Four Case Studies
    Charles M. Lepkowsky · 2017 · Activitas Nervosa Superior
  5. Unilateral Vocal Fold Paralysis in Parkinson Disease: Case Report and Review of the Literature
    Abdul‐Latif Hamdan, Elie Khalifee, Georges S. Tabet · 2017 · Journal of Voice
  6. PARKINSON’S DISEASE- A REVIEW
    Supriya Krishna, Sandhya Prasad, Rohit Kumar Goel · 2018 · Journal of Evolution of Medical and Dental Sciences
  7. L-3-n-butylphthalide soft capsules in the treatment of Parkinson disease dementia
    Rui Zhong, Qingling Chen, Xinyue Zhang · 2019 · Medicine
  8. Acoustic analysis of the voice in patients with Parkinson's disease and hypokinetic dysarthria
    Sara Fernández-García, Cristina Gabriela Dumitrache, José A. González · 2020 · Revista de Logopedia Foniatría y Audiología
  9. Glutathione S-Transferase Alpha 4 Prevents Dopamine Neurodegeneration in a Rat Alpha-Synuclein Model of Parkinson’s Disease
    Michael A S Jewett, Elna Dickson, Kajsa Atterling Brolin, Matilde Negrini, Itzia Jiménez-Ferrer, Maria Swanberg · 2018 · Frontiers in Neurology
  10. A Novel Face-based Approach for the Early Diagnosis of Parkinson’s Disease
    Chang-jiang Hu, Peng Zhang, Wei Huang · 2021
  11. NeuroDiag: Software for Automated Diagnosis of Parkinson’s Disease Using Handwriting
    Quoc Cuong Ngo, Nicole McConnell, Mohammod Abdul Motin, Barbara Polus, Arup Bhattacharya, Sanjay Raghav, Dinesh Kumar · 2024 · IEEE Journal of Translational Engineering in Health and Medicine
  12. Application of ResLSTM in Hypomimia Video Detection for Parkinson's Disease
    Zhou-Xiang Xu, Dongxu Lv, Haoyu Li, Hong Li, Hebei Gao · 2023 · International Conference on New Trends in Computational Intelligence (NTCI)
  13. New Mechanism for the Apoptosis of Human Neuroblastoma Cells by the Interaction between Fluorene-9-Bisphenol and the G Protein-Coupled Estrogen Receptor 1
    Xiuchang Liu, Zhi Cheng, Xueliang Shang · 2024 · Environmental Science & Technology
  14. Bee venom as a promising therapeutic strategy in central nervous system diseases
    Zeinab Vahidinia, Shirin Barati, Abolfazl Azami Tameh, Saeid Bagheri‐Mohammadi, Ali Garshasebi · 2024 · Neuropeptides
  15. Unveiling the Cutting Edge: Recent Developments in α-Synuclein Nano-biosensor Technology for Precision Diagnosis of Parkinson’s Disease
    Romi Shreshtha, Aditya Mulukutla, Vishal Kumar Deb, Nidhi Chauhan, Utkarsh Jain · 2025 · BioNanoScience
  16. Phenolamides from Rootstocks of Lycium ruthenicum Murr by Ligand Fishing and Their Neuroprotective Effects
    Yi‐Kao Hu, Ayzohra Ablat, Xiaolin Bai · 2025 · Journal of Agricultural and Food Chemistry
  17. Automated Parkinson’s Disease Diagnosis Using Decomposition Techniques and Deep Learning for Accurate Gait Analysis
    S. Jeba Priya, C. Anand Deva Durai, M. S. P. Subathra, Selvaraj Thomas George, Andrew Jeyabose · 2025 · IEEE Access
  18. Regulation of the antioxidant structure of polydopamine nanomaterials: Mechanisms, strategies, and applications in reactive oxygen species-mediated diseases
    Wen Lin, Hu Miao, Jin Zhang, Jiayu Li, Xin Lv, Xin Ding, Yi Liu, Yan-Jun Hu · 2025 · Next Materials
  19. Sirtuins in Parkinson's disease: Molecular mechanisms and pathophysiological roles
    Xiang Li, Xue‐Qun Luo, Xueqin Cao, Elizabeth Rosalind Thomas, Wenjun Wang, Xiaogang Zhou, Shiying Zhou, Anguo Wu, Ruixia Gao, Kezhi Liu et al. · 2025 · Ageing Research Reviews
  20. Primary central nervous system lymphoma presenting with Parkinsonism as an initial manifestation: A case report and literature review
    Rintaro Okano, Kohei Suzuki, Yoshiteru Nakano · 2021 · Molecular and Clinical Oncology
  21. Long-Term Motor Cortical Electrical Stimulation Ameliorates 6-Hydroxydopamine-Induced Motor Dysfunctions and Exerts Neuroprotective Effects in a Rat Model of Parkinson’s Disease
    Chi-Wei Kuo, Ming‐Yuan Chang, Ming-Yi Chou et al. · 2022 · Frontiers in Aging Neuroscience
  22. An innovative biodevice towards monitoring of miR-153 using specific DNA immobilized on the surface of poly(chitosan) decorated AgNPrs/GQDs-CysA conductive nano-ink: Early-stage diagnosis of Parkinson’s disease using biosensor technology
    Esmaeil Darvish Aminabad, Mohammad Hasanzadeh, Arezoo Saadati, Mohammad Ali Hosseinpour Feizi, Reza Safaralizadeh, Ahmad Mobed · 2022 · Materials Science and Engineering B
  23. Effects of Levodopa‐Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study
    Sun Ju Chung, Matilde Calopa, Maria Gabriella Ceravolo, Nicola Tambasco, Angelo Antonini, К. Ray Chaudhuri, Weining Robieson, Olga Sánchez‐Soliño, Cindy Zadikoff, Man Jin et al. · 2022 · Parkinson s Disease
  24. Salivary Biomarkers: Noninvasive Ways for Diagnosis of Parkinson’s Disease
    Sanaz Salaramoli, Hamidreza Joshaghani, Seyed Isaac Hashemy · 2023 · Neurology Research International
  25. Integrated proteomics and metabolomics reveals metabolism disorders in the α-syn mice and potential therapeutic effect of Acanthopanax senticosus extracts
    Jiaqi Fu, Xin Gao, Yi Lu, Fang Lü, Yu Wang, Pingping Chen, Chong‐Zhi Wang, Chun‐Su Yuan, Shumin Liu · 2023 · Journal of Ethnopharmacology
  26. Curcumin neuroprotective effects in Parkinson disease during pregnancy
    Faramarz Khosravi, Vida Hojati, Sepideh Mirzaei · 2023 · Brain Research Bulletin
  27. Effects of protective step training on proactive and reactive motor adaptations in Parkinson’s disease patients
    Thurmon E. Lockhart, Chris Frames, Markey C. Olson, Seong H. Moon, Dan Peterson, ABRAHAM N. LIEBERMAN · 2023 · Frontiers in Neurology
  28. Long-term efficacy of hydrotherapy on balance function in patients with Parkinson’s disease: a systematic review and meta-analysis
    Zicai Liu, Miao Huang, Ya Liao · 2023 · Frontiers in Aging Neuroscience
  29. Protective effect of sterubin against neurochemical and behavioral impairments in rotenone-induced Parkinson's disease
    May Majed Alqurashi, Fahad Ahmed Al-Abbasi, Muhammad Afzal, Amira M. Alghamdi, Mustafa Zeyadi, Ryan Adnan Sheikh, Sultan Alshehri, Syed Sarim Imam, Nadeem Sayyed, Imran Ahmed Kazmi · 2024 · Brazilian Journal of Medical and Biological Research
  30. Mitochondrial stress-induced H4K12 hyperacetylation dysregulates transcription in Parkinson’s disease
    Minhong Huang, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, Anumantha G. Kanthasamy · 2024 · Frontiers in Cellular Neuroscience
  31. From onset to advancement: the temporal spectrum of α-synuclein in synucleinopathies
    James A. Wiseman, Kreesan Reddy, Birger Victor Dieriks · 2024 · Ageing Research Reviews
  32. Klotho: An emerging factor in neurodegenerative diseases
    Gauri Pathare, Kavita K. Shalia · 2019 · Biomedical Research Journal
  33. Polar Expression Feature of Digitized Handwritten Pattern for Automated- Parkinson’s-Disease Screening Using Perceptual Color Representation-Based Classifier
    Ping-Ju Kan, Chia‐Hung Lin, Chen-San Su, Hsin‐Yu Lin, Weiling Chen, Chih‐Kuang Liang · 2019 · IEEE Access
  34. Monitoring Older People: An Overview of Devices Responding to Significant Needs of Elderly Affected by Parkinson’s Disease
    Silvia Imbesi, Giuseppe Mincolelli · 2019 · Advances in intelligent systems and computing
  35. Parkinson’s Disease Rehabilitation: Effectiveness Approaches and New Perspectives
    Luciana Auxiliadora de Paula Vasconcelos · 2019 · IntechOpen eBooks
  36. Unilateral accumbal dopamine depletion affects decision-making in a side-specific manner.
    A. M. Cunha, Fábio G. Teixeira, M. R. Guimarães, M. Esteves, Joana Pereira-Mendes, Ana Rosa Soares, A. Almeida, Nuno Sousa, António J. Salgado, H. Leite-Almeida · 2020 · Experimental Neurology
  37. Disruptions of cortico-kinematic interactions in Parkinson’s disease
    John McLinden, Roohollah Jafari Deligani, Mohammadreza Abtahi · 2021 · Behavioural Brain Research
  38. Neuroprotective effect of neferine, an alkaloid against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease mouse model
    Shendong Jing, Zhenhai Wang, Jun Zhang, Xianfeng Li, Ruifei Huang · 2021 · Pharmacognosy Magazine
  39. ParkinsonCom Project: Towards a Software Communication Tool for People with Parkinson’s Disease
    Káthia Marçal de Oliveira, Élise Batselé, Sophie Lepreux et al. · 2021 · Lecture notes in computer science
  40. Screening of Parkinson’s Differential MicroRNA Based on GEO Database and Its Clinical Verification
    Xuping Jiang, Lili Xiao, Xumei Jiang, Guangsheng Li, Zhijuan Lu · 2021 · BioMed Research International
  41. Association of ADAM10 gene variants with sporadic Parkinson's disease in Chinese Han population
    Miaomiao Zhou, Yuwan Lin, Lin Lu, Zhiling Zhang, Wenyuan Guo, Guoyou Peng, Wenlong Zhang, Ziting Zhu, Zhuohua Wu, Mingshu Mo et al. · 2021 · The Journal of Gene Medicine
  42. Therapeutic Molecular Insights into the Active Engagement of Cannabinoids in the Therapy of Parkinson’s Disease: A Novel and Futuristic Approach
    Vaibhav Jain, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Hafiz Antar Makeen, Mohammed Albratty, Abdulkarim M. Meraya, Asim Najmi · 2022 · Neurotoxicity Research
  43. Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review
    Wan‐Ling Alyssa Chiew, David Mathew, Chandra Mohan Kumar, Edwin Chuen Ping Seet, Farnad Imani, Seyed-Hossein Khademi · 2023 · Anesthesiology and Pain Medicine
  44. Expression of prion protein in the cerebrospinal fluid of patients with Parkinson’s disease complicated with rapid eye movement sleep behavior disorder
    W.J. Zhang, Xiuli Shang, J. Peng, Miaomiao Zhou, Wenli Sun · 2017 · Genetics and Molecular Research
  45. Combination therapy of scalp electro-acupuncture and medication for the treatment of Parkinson's disease: A systematic review and meta-analysis
    Tianyao Qiang, Cong Gai, Yuan Chai · 2019 · Journal of Traditional Chinese Medical Sciences
  46. Prevalence of temporomandibular joint disorder in people with Parkinson’s disease in a public university hospital
    Renato Mariano da Silva, Vilma Lucia dos Santos, Taysa Vannoska de Almeida Silva · 2019 · Revista CEFAC
  47. Impact of Physiotherapy Absence in COVID-19 Pandemic on Neurological State of Patients With Parkinson Disease
    Alen Kapel, Domen Serdoner, Ester Fabiani, Tomaž Velnar · 2021 · Topics in Geriatric Rehabilitation
  48. Effects of cueing techniques on gait, gait-related mobility, and functional activities in patients with Parkinson’s disease: a systematic review and meta-analysis
    Assmaa Magdi, Asma Mohammed Sayed Ahmed, Esraa Elsayed, Razan Ahmad, Senthilnathan Ramakrishnan, Marian Grace Gabor · 2021 · Physical Therapy Reviews
  49. Possible therapies of Parkinson’s disease: A review
    Ashok K. Chakraborty, Sam Brauer, Anil R. Diwan · 2020 · Journal of Clinical Neuroscience
  50. Pose-based tremor type and level analysis for Parkinson’s disease from video
    Haozheng Zhang, Edmond S. L. Ho, Xiatian Zhang · 2024 · International Journal of Computer Assisted Radiology and Surgery
  51. Pathophysiological and therapeutic implications of neuropeptide S system in neurological disorders
    Kamini R Shirasath, Vaishnavi K. Patil, Sanjay N. Awathale, Sameer N. Goyal, Kartik Tularam Nakhate · 2024 · Peptides
  52. The role of autophagy in Parkinson’s disease: a gender difference overview
    Laura Cucinotta, Deborah Mannino, Alessia Filippone, Adele Romano, Emanuela Esposito, Irene Paterniti · 2024 · Frontiers in Pharmacology
  53. Spectrum of Non-Motor Symptoms in Parkinson’s Disease — a Review
    Syed Zohair Husain Rizvi, Vikram Palimar, Chandni Gupta, Lydia S. Andrade · 2024 · Annals of Clinical and Experimental Neurology
  54. Speech-in-noise hearing impairment is associated with increased risk of Parkinson's: A UK biobank analysis
    Megan Rose Readman, Yang Wang, Fang Wan, Ian Fairman, Sally A. Linkenauger, Trevor J. Crawford, Christopher J. Plack · 2024 · Parkinsonism & Related Disorders
  55. Genetic mutations in kinases: a comprehensive review on marketed inhibitors and unexplored targets in Parkinson's disease
    Amir Raza, Jeevika Raina, Sanjeev Kumar Sahu, Pankaj K. Wadhwa · 2025 · Neurological Sciences
  56. Chemical exchange saturation transfer MRI for neurodegenerative diseases: An update on clinical and preclinical studies
    Ahelijiang Saiyisan, Shihao Zeng, Huabin Zhang, Ziyan Wang, Jiawen Wang, Pei Cai, Jianpan Huang · 2025 · Neural Regeneration Research
  57. Female mice exhibit resistance to disease progression despite early pathology in a transgenic mouse model inoculated with alpha-synuclein fibrils
    Stéphanie Tullo, Janice Park, Daniel Gallino, Megan Park, Kristie Mar, Vladislav Novikov, Rodrigo Sandoval Contreras, Raihaan Patel, Esther del Cid‐Pellitero, Edward A. Fon et al. · 2025 · Communications Biology
  58. Diagnostic value of transcranial ultrasonography and clinical features for Parkinson’s disease based on XGBoost model and SHAP visualization analysis: a retrospective study
    Yanan Ge, Xuelei Zhang, Xiaoming Ding, Panpan Zhang, Liyang Su, Gang Wang · 2025 · European Radiology
  59. The role of gasotransmitters in Parkinson's disease: Interplay of nitric oxide, carbon monoxide, and hydrogen sulfide
    Jennifer L. O'Connor, Dionisia M. Fountos, Bita Firouzan, Fateme Azizi, Rasoul Ghasemi, Khosrow Kashfi · 2025 · Neurotherapeutics
  60. Exercise Ameliorates Dopaminergic Neurodegeneration in Parkinson’s Disease Mice by Suppressing Microglia-Regulated Neuroinflammation Through Irisin/AMPK/Sirt1 Pathway
    Bin Wang, Nan Li, Yuanxin Wang, Xin Tian, Junjie Lin, Xin Zhang, Haocheng Xu, Yu Sun, Renqing Zhao · 2025 · Biology
  61. The effect of diet on Parkinson’s disease progression, symptoms and severity: a review of randomised controlled trials
    Aakash Prasad, Connie Glover, Marshall G Hussain Shuler, Viswas Dayal, Fiona E. Lithander · 2025 · Proceedings of The Nutrition Society
  62. Rethinking early Alzheimer’s disease: An impaired internal model updating disorder?
    Annibale Antonioni · 2026 · Neuroscience & Biobehavioral Reviews
  63. Stem Cell-based and Advanced Therapeutic Modalities for Parkinson’s Disease: A Risk-effectiveness Patient-centered Analysis
    Nikoo Hossein‐Khannazer, Massoud Vosough, Sarvenaz Salahi, Maryam Alsadat Mousavi, Gholamreza Azizi · 2022 · Current Neuropharmacology
  64. Weighting for the Beat: Using a Dance Cue to Facilitate Turning in People with Parkinson’s Disease and Freezing of Gait
    Elmar C. Kal, Toby Jack Ellmers, Anna Fieldwalker · 2022 · Journal of Parkinson s Disease
  65. Neuropathology of Parkinson's Disease
    Bilal El‐Mansoury, Omar El Hiba, Mustapha Agnaou, Arumugam Radhakrishan Jayakumar, Abdelaati El Khiat, Kholoud Kahim, Samira Boulbaroud, Nadia Zouhairi, Oumaima Tibssirte, Hayat Bouighajd et al. · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  66. Effects of activity-oriented physiotherapy with and without eye movement training on dynamic balance, functional mobility, and eye movements in patients with Parkinson’s disease: An assessor-blinded randomised controlled pilot trial
    Sarah Mildner, Isabella Hotz, Franziska Kübler, Linda Katharina Rausch, Michaela Stampfer‐Kountchev, Johanna Panzl, Christian Brenneis, Barbara Seebacher · 2024 · PLoS ONE
  67. The Tree Shrew Model of Parkinson Disease: A Cost-Effective Alternative to Nonhuman Primate Models
    Hao Li, Leyi Mei, Xiupeng Nie, Liping Wu, Longbao Lv, Xiaofeng Ren, Jitong Yang, Haonan Cao, Jing Wu, Yuhua Zhang et al. · 2024 · Laboratory Investigation
  68. Deciphering the role of neuropeptides as biomarkers for early diagnosis of Parkinson's disease
    Jhanvi Thakur, Angel Pavalu Godad · 2025 · Life Sciences
  69. Impact of Footwear and Foot Deformities in patients with Parkinson's disease: A Case-Series Study
    Eloy Trillo Novo, Daniel López‐López, Carmen de Labra, Marta Elena Losa‐Iglesias, Ricardo Vallejo, César Calvo‐Lobo, Carlos Romero Morales, Marta San‐Antolín · 2020 · International Journal of Medical Sciences
  70. Association study of MCCC1/LAMP3 and DGKQ variants with Parkinson’s disease in patients of Malay ancestry
    Jia Lun Lim, Ebonne Yulin Ng, Shen‐Yang Lim et al. · 2021 · Neurological Sciences
  71. Emerging Targets for the Diagnosis of Parkinson’S Disease: Examination of Systemic Biomarkers
    Lara Cheslow, Adam Eugene Snook, Scott Arthur Waldman · 2021 · Biomarkers in Medicine
  72. Neuroprotective effects of tanshinone IIA in experimental model of Parkinson disease in rats
    Zhang Li, Qiangzi Li · 2022 · Arabian Journal of Chemistry
  73. A novel socially assistive robotic platform for cognitive-motor exercises for individuals with Parkinson's Disease: a participatory-design study from conception to feasibility testing with end users
    Dor Raz, Shirel Barkan-Slater, Ilanit Baum-Cohen, Gal Vissel, Yeela Lahav-Raz, Amir Shapiro, Shelly Levy‐Tzedek · 2023 · Frontiers in Robotics and AI
  74. Impact of caregiver relationship on self‐care in patients with Parkinson's disease: A cross‐sectional study using Riegel's theory of self‐care of chronic illness
    JuHee Lee, Misook Lee Chung, Eun-Young Kim, Jee‐Hye Yoo · 2023 · Journal of Clinical Nursing
  75. Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review
    Pooja Devi Nongthombam, Reena Haobam · 2024 · Molecular Biology Reports
  76. Exploring risk factors and predicting UPDRS score based on Parkinson's speech signals
    Jianxin Zhang, Weifeng Xu, Qiang Zhang · 2017 · IEEE International Conference on e-Health Networking, Applications and Services (Healthcom)
  77. The role of neuronal nitric oxide and its pathways in the protection and recovery from neurotoxin-induced de novo hypokinetic motor behaviors in the embryonic zebrafish (Danio rerio)
    Amber Woodard, Brandon Barbery, Reid Wilkinson et al. · 2019 · AIMS neuroscience
  78. Perspectives on the urological care in Parkinson’s disease patients
    Mohamad Ahmad Moussa, Mohamad Abou Chakra, Athanasios Papatsoris, Athanasios Dellis, Baraa Dabboucy, Michaël Peyromaure, Nicolas Barry Delongchamps, Hugo Bailly, Igor Duquesne · 2022 · Archivio Italiano di Urologia e Andrologia
  79. Derivation and Analysis of Dynamic Handwriting Features as Clinical Markers of Parkinson’s Disease
    Christine Poon, Niku Gorji, Mark D. Latt, Kelvin K.F. Tsoi, Boris Choi, Clement T. Loy, Simon Kar-Sing Poon · 2019 · Hawaii International Conference on System Sciences (HICSS)
  80. Parkinson's disease
    W. Philip Bartel, Victor S. Van Laar, Edward A. Burton · 2020 · Elsevier eBooks
  81. L -Ergothioneine ameliorates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease in C57BL/6J mice by activating DJ-1
    Xianshe Meng, Huawen Meng, Shuzeng Hou, Zequn Yin, Xuerui Wang, Ke Gong, Feng Zhang, Qingshan Li, Shuang Zhang, Yuanli Chen et al. · 2024 · Food Science and Human Wellness
  82. Targeting Neurodegeneration: The Emerging Role of Hybrid Drugs
    Debasmita Deb, Meenakshi Dhanawat, Bharat Bhushan, Lalduhsanga Pachuau, Nirupam Das · 2025 · Current Drug Targets
  83. Albiflorin ameliorates neuroinflammation and exerts neuroprotective effects in Parkinson’s disease models
    Yuan Gao, Yanmei Chen, Ning Wang, Qiang Meng · 2025 · Immunopharmacology and Immunotoxicology
  84. Characterization and neurotherapeutic evaluation of venom polypeptides identified from Vespa magnifica: The role of Mastoparan-M in Parkinson’s disease intervention
    Chaojie Liu, Xiaoyu Li, Mingran Chen, Yunyun Liu, Kunkun Li, Dexiao Wang, Zhibin Yang, Yunjiao Guo, Yu Zhao, Hairong Zhao et al. · 2025 · Journal of Ethnopharmacology
  85. The Role of Virtual Reality on Parkinson’s Disease Management: A Bibliometric and Content Analysis
    Qiang Wu, Mengli Qiu, Xiaomei Liu, Wanjia He, Ting Yang, Chengsen Jia · 2025 · Sensors
  86. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta‐Analysis
    Obai Yousef, Moaz Elsayed Abouelmagd, Hala Khaddam, Abdulrahman Shbani, Raneem Yousef, Mostafa Mahmoud Meshref, Ibrahem Hanafi · 2025 · Journal of Sleep Research
  87. Modulation of Electron Transport via Target Recognition in Asymmetric Nanochannel Arrays for Enantiomer Detection
    Xuemei Shang, Mei Jun Yang, Tiantian Su, Junli Guo, Chen Xi Zhao, Pei Song, Yan‐Yan Song, Yucen Li · 2025 · Analytical Chemistry
  88. Vision-skeleton dual-modality framework for generalizable assessment of Parkinson’s disease gait
    Weiping Liu, Xiaozhen Lin, Xinghong Chen, Yifang Liu, Zengxin Zhong, Rong Chen, Guannan Chen, Lin Yu · 2025 · Medical Image Analysis
  89. Exploring the link between dopamine dysregulation and eating disorders: A narrative review
    Zoaib Habib Tharwani, Sean Kaisser Shaeen, Komal Zahid, Shahzaib Ahmed, Rania Naqrashi, Amir Murtaza, Sanila Mughal, Muhammad Hasanain, Muhammad Umair Anjum, Mohammed Mahmmoud Fadelallah Eljack et al. · 2025 · Journal of Neuroendocrinology
  90. Smart Nanomedicines for Neurodegenerative Diseases: Empowering New Therapies with Molecular Imaging and Artificial Intelligence
    Jaison Jeevanandam, Grygoriy Tsenov, Michael K. Danquah, Daniel Ruiz‐Molina, Stergios Boussios, Saak Victor Ovsepian · 2025 · Molecular Diagnosis & Therapy
  91. The role of immune cells in the course of Parkinson's disease
    Xiuying He, Ru‐Rong Wang, Ting‐Hua Wang · 2021 · Ibrain
  92. Effectiveness of Botulinum Toxin on Hand Tremor Intensity and Upper Limb Function in Patients with Parkinson’s Disease: Results of a Systematic Review
    Fariba Eslamian, Neda Dolatkhah, Leila Fallah, Fatemeh Jahanjoo, Vahideh Toopchizadeh, Mahnaz Talebi · 2023 · Tremor and Other Hyperkinetic Movements
  93. Clinical and cost-effectiveness of ‘Live Well with Parkinson’s’ self-management intervention versus treatment as usual for improving quality of life for people with Parkinson’s: study protocol for a randomised controlled trial
    Kate R Walters, Megan Armstrong, Benjamin Gardner, Gareth Ambler, Rachael Maree Hunter, Bev Maydon, Nathan Davies, Catherine Atkinson, Richard G. Brown, Tasmin Rookes et al. · 2023 · Trials
  94. The onset of motor learning impairments in Parkinson’s disease: a computational investigation
    Ilaria Gigi, Rosa Senatore, Angelo Marcelli · 2024 · Brain Informatics
  95. Integrated bioinformatics analysis for exploring potential biomarkers related to Parkinson’s disease progression
    Zhenchao Huang, En’peng Song, Zhijie Chen · 2024 · BMC Medical Genomics
  96. Long-Term Impact of Deep Brain Stimulation in Parkinson’s Disease: Does It Affect Rehabilitation Outcomes?
    Margherita Canesi, Lorenzo Lippi, Simone Rivaroli · 2024 · Medicina
  97. Dietary Natural Flavonoids: Intervention for MAO ‐B Against Parkinson's Disease
    Ashini Singh, Suman Sinha, Niraj Kumar Singh · 2024 · Chemical Biology & Drug Design
  98. Discovery of Novel Procaine‐Imidazole Derivative as Inhibitor of Monoamine Oxidase‐B for Potential Benefit in Parkinson's Disease
    Jiane Wu, Qionghua Liu, Yuping Hu · 2020 · ChemistrySelect
  99. Neuronal TNFα , Not α‐Syn, Underlies PDD ‐Like Disease Progression in IFNβ‐KO Mice
    Erika B. Villanueva, Emilie Tresse, Yawei Liu, João N. Duarte, Gisela Jimenez‐Duran, Patrick Ejlerskov, Oliver Kretz, Desirée Loreth, Tobias Goldmann, Marco Prinz et al. · 2021 · Annals of Neurology
  100. Natural history and patterns of treatment change in Parkinson’s disease: A retrospective chart review
    Prakash Navaratnam, Steve Arcona, Howard Steven Friedman, Matthew J. Leoni, Shajahan Shaik, Rahul Sasané · 2021 · Clinical Parkinsonism & Related Disorders